Figure 1. Cumulative Incidence Of Asthma-related Deaths In The 28-week Salmeterol Multi-center Asthma Research Trial (smart), By Duration Of Treatment (9e0bdea8 Df9b 4873 B24b 919cebff5edd 01)
Advair
Product Images NDC 21695-196
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Advair (NDC 21695-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fluticasone Propionate Chemical Structure (9e0bdea8 Df9b 4873 B24b 919cebff5edd 02)
Salmeterol Xinafoate Chemical Structure (9e0bdea8 Df9b 4873 B24b 919cebff5edd 03)
Figure 2. Mean Percent Change From Baseline In Fev1 In Patients With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (study 1) (9e0bdea8 Df9b 4873 B24b 919cebff5edd 04)
Figure 3. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (9e0bdea8 Df9b 4873 B24b 919cebff5edd 05)
This appears to be a description of an asthma medication called "ADVAIR DSKIS 100/E0" and its components, including "Saimeteni0imcy" and "Futasone prpitat 100 g ke caly". It also lists various dosages and references a "Baseline".*
Figure 4. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (9e0bdea8 Df9b 4873 B24b 919cebff5edd 06)
Figure 5. Predose Fev1: Mean Percent Change From Baseline In Patients With Chronic Obstructive Pulmonary Disease (9e0bdea8 Df9b 4873 B24b 919cebff5edd 07)
Figure 6. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Patients With Chronic Obstructive Pulmonary Disease (9e0bdea8 Df9b 4873 B24b 919cebff5edd 08)
This appears to be a record of medication dosages and their impact on a patient's FEV (Forced Expiratory Volume). The three medications mentioned are Advair Diskus 250/50, Fluticasone Propionate 250 mcg/day, and a placebo. The numeric values next to each medication appear to be the patient's baseline FEV before the medication is taken (in liters). The last section of the text appears to be some sort of chart or table, with numerical values listed for each medication, but the context is unclear.*
Diskus Parts (9e0bdea8 Df9b 4873 B24b 919cebff5edd 09)
The text appears to be a list of items or features of an unknown product. The item includes a "lever," "mouthpiece," "dose indicator," "thumb grip," and an "outer case." It is not clear what type of product these items belong to.*
Figure 1 (9e0bdea8 Df9b 4873 B24b 919cebff5edd 10)
Figure 2 (9e0bdea8 Df9b 4873 B24b 919cebff5edd 11)
Figure 3 (9e0bdea8 Df9b 4873 B24b 919cebff5edd 12)
Figure 4 (9e0bdea8 Df9b 4873 B24b 919cebff5edd 13)
Figure 5 (9e0bdea8 Df9b 4873 B24b 919cebff5edd 14)
Figure 6 (9e0bdea8 Df9b 4873 B24b 919cebff5edd 15)
Advair 250/50mcg (9e0bdea8 Df9b 4873 B24b 919cebff5edd 16)
This is a description of a medication with the product ID RA019601. It is a prescription drug called Advair Diskus 250/50mcg and comes in a powder inhaler with lactose. The inhaler contains 250mcg of fluticasone propionate and 72.5mcg of salmeterol xinafoate, equivalent to 50mcg of salmeterol base. The package insert has further details, and it is manufactured by Glaxo Operations UK Ltd in England. It is distributed in Thousand Oaks, CA and must be kept out of the reach of children.*
Advair 500/50mcg (9e0bdea8 Df9b 4873 B24b 919cebff5edd 17)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
